JP2020531500A5 - - Google Patents

Download PDF

Info

Publication number
JP2020531500A5
JP2020531500A5 JP2020510573A JP2020510573A JP2020531500A5 JP 2020531500 A5 JP2020531500 A5 JP 2020531500A5 JP 2020510573 A JP2020510573 A JP 2020510573A JP 2020510573 A JP2020510573 A JP 2020510573A JP 2020531500 A5 JP2020531500 A5 JP 2020531500A5
Authority
JP
Japan
Prior art keywords
compound
formula
solvate
mirror
hydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020510573A
Other languages
English (en)
Japanese (ja)
Other versions
JP7399846B2 (ja
JP2020531500A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/000358 external-priority patent/WO2019040109A1/en
Publication of JP2020531500A publication Critical patent/JP2020531500A/ja
Publication of JP2020531500A5 publication Critical patent/JP2020531500A5/ja
Priority to JP2023205964A priority Critical patent/JP7665000B2/ja
Application granted granted Critical
Publication of JP7399846B2 publication Critical patent/JP7399846B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

JP2020510573A 2017-08-21 2018-08-20 (s)-tert-ブチル4,5-ジアミノ-5-オキソペンタノエートの調製プロセス Active JP7399846B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023205964A JP7665000B2 (ja) 2017-08-21 2023-12-06 (s)-tert-ブチル4,5-ジアミノ-5-オキソペンタノエートの調製プロセス

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762548268P 2017-08-21 2017-08-21
US62/548,268 2017-08-21
PCT/US2018/000358 WO2019040109A1 (en) 2017-08-21 2018-08-20 PROCESSES FOR THE PREPARATION OF (S) -TERT-BUTYL 4,5-DIAMINO-5-OXOPENTANOATE

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023205964A Division JP7665000B2 (ja) 2017-08-21 2023-12-06 (s)-tert-ブチル4,5-ジアミノ-5-オキソペンタノエートの調製プロセス

Publications (3)

Publication Number Publication Date
JP2020531500A JP2020531500A (ja) 2020-11-05
JP2020531500A5 true JP2020531500A5 (cg-RX-API-DMAC7.html) 2021-10-21
JP7399846B2 JP7399846B2 (ja) 2023-12-18

Family

ID=63794593

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020510573A Active JP7399846B2 (ja) 2017-08-21 2018-08-20 (s)-tert-ブチル4,5-ジアミノ-5-オキソペンタノエートの調製プロセス
JP2023205964A Active JP7665000B2 (ja) 2017-08-21 2023-12-06 (s)-tert-ブチル4,5-ジアミノ-5-オキソペンタノエートの調製プロセス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023205964A Active JP7665000B2 (ja) 2017-08-21 2023-12-06 (s)-tert-ブチル4,5-ジアミノ-5-オキソペンタノエートの調製プロセス

Country Status (8)

Country Link
US (4) US10717703B2 (cg-RX-API-DMAC7.html)
EP (1) EP3672939A1 (cg-RX-API-DMAC7.html)
JP (2) JP7399846B2 (cg-RX-API-DMAC7.html)
CN (2) CN111032628A (cg-RX-API-DMAC7.html)
AU (1) AU2018321548B2 (cg-RX-API-DMAC7.html)
CA (2) CA3310811A1 (cg-RX-API-DMAC7.html)
MX (1) MX2020002010A (cg-RX-API-DMAC7.html)
WO (1) WO2019040109A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113573719A (zh) 2018-11-08 2021-10-29 朱诺治疗学股份有限公司 治疗和t细胞调节的方法和组合
CN111606837A (zh) * 2020-06-15 2020-09-01 千辉药业(安徽)有限责任公司 一种维格列汀的合成方法
JP2024524851A (ja) * 2021-06-11 2024-07-09 大塚製薬株式会社 Erk阻害剤を調製するプロセス
KR20240040769A (ko) * 2021-07-26 2024-03-28 아비나스 오퍼레이션스, 인코포레이티드 이작용성 화합물을 제조하는 방법
CN114478324B (zh) * 2021-12-30 2023-07-07 上海嘉莱多生物技术有限责任公司 一种活性化合物及其在侧链羧基类化合物保护的应用
AR133800A1 (es) 2023-09-13 2025-11-05 Bristol Myers Squibb Co Compuestos de oxoisoindolinil piperidina-2,6-diona sustituida

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3989812A (en) 1974-08-09 1976-11-02 Smithkline Instruments, Inc. Folic acid derivatives and use in radio-assay
CH613709A5 (en) 1975-12-10 1979-10-15 Ciba Geigy Ag Process for the preparation of glucosamine derivatives
JPS55111499A (en) 1979-02-21 1980-08-28 Takeda Chem Ind Ltd Glucosamine derivative and its preparation
US4406889A (en) 1980-02-15 1983-09-27 Ciba-Geigy Corporation Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use
US4481190A (en) 1982-12-21 1984-11-06 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
JPS611651A (ja) 1984-06-12 1986-01-07 Toyama Chem Co Ltd N−アシル酸性アミノ酸ジアミド類およびその製造法並びにそれらを含有する抗潰瘍剤
US4690916A (en) 1984-11-13 1987-09-01 Syntex (U.S.A.) Inc. Nona and decapeptide analogs of LHRH useful as LHRH antagonists
US5556982A (en) 1985-01-14 1996-09-17 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US4897255A (en) 1985-01-14 1990-01-30 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US5175343A (en) 1985-01-14 1992-12-29 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
HUT46044A (en) 1986-11-21 1988-09-28 Richter Gedeon Vegyeszet Process for producing immunstimulant peptides inhibiting multiplication of leukaemic cells and pharmaceutics comprising same
US4988496A (en) 1988-05-31 1991-01-29 Neorx Corporation Metal radionuclide chelating compounds for improved chelation kinetics
IN173794B (cg-RX-API-DMAC7.html) 1988-12-15 1994-07-16 Council Of Scient & Ind Res Ra
US5270302A (en) 1988-12-21 1993-12-14 Abbott Laboratories Derivatives of tetrapeptides as CCK agonists
HU205147B (en) 1989-06-29 1992-03-30 Sandoz Ag Process for producing muramyl dipeptide derivative and pharmaceutical compostions comprising same
IN177680B (cg-RX-API-DMAC7.html) 1990-05-08 1997-02-15 Council Scient Ind Res
US5312831A (en) 1993-05-12 1994-05-17 American Cyanamid Company Urethanes and ureas that induce cytokine production
GB9326518D0 (en) 1993-12-29 1994-03-02 Sandoz Ltd Organic compounds
GB9408936D0 (en) 1994-05-05 1994-06-22 Cancer Res Inst Anti-cancer compounds
DE19505932B4 (de) * 1995-02-21 2005-06-23 Degussa Ag Verfahren zur Herstellung von Oxazolidinonen, neue Oxazolidinone sowie Verwendung von Oxazolidinonen
US5710129A (en) 1995-02-23 1998-01-20 Ariad Pharmaceuticals, Inc. Inhibitors of SH2-mediated processes
US5635504A (en) 1995-06-07 1997-06-03 Bristol-Myers Squibb Co. Diazepine containing dual action inhibitors
IN184769B (cg-RX-API-DMAC7.html) 1995-07-20 2000-09-30 Council Scient Ind Res
JPH09165370A (ja) 1995-10-13 1997-06-24 Fuji Yakuhin Kogyo Kk ラクタム誘導体およびその塩
GB9524267D0 (en) 1995-11-28 1996-01-31 Isis Innovation Enzyme inhibitor and method
AU2277597A (en) 1996-02-23 1997-09-10 Ariad Pharmaceuticals, Inc. New inhibitors of sh2-mediated processes
US6117896A (en) 1997-02-10 2000-09-12 Molecumetics Ltd. Methods for regulating transcription factors
US6153596A (en) 1996-12-18 2000-11-28 Emory University Polycationic oligomers
US6410576B1 (en) 1998-07-28 2002-06-25 Santen Pharmaceutical Co., Ltd. Thiazolidine derivatives
JP2000219663A (ja) 1998-11-24 2000-08-08 Taiho Yakuhin Kogyo Kk Nδ−置換アミノオルニチン誘導体及びその塩
AU2001252921A1 (en) 2000-04-18 2001-10-30 Eli Lilly And Company A glycopeptide and preparation thereof
US7169919B2 (en) 2000-04-18 2007-01-30 Eli Lilly And Company Process for preparing lipid II
US7662960B2 (en) 2001-04-26 2010-02-16 Choongwae Pharma Corporation Beta-strand mimetics and method relating thereto
AU2002950136A0 (en) 2002-07-11 2002-09-12 La Trobe University N-methyl amino acids
AU2003236750B2 (en) 2002-08-22 2006-08-10 Victhom Human Bionics Inc. Actuated leg prosthesis for above-knee amputees
CN100522995C (zh) 2003-10-22 2009-08-05 中国医学科学院药物研究所 胞壁酰-丙氨酰-d-异谷氨酰胺衍生物、制法和其药物组合物与用途
US20050187138A1 (en) 2004-02-24 2005-08-25 The Regents Of The University Of California, A California Corporation Peptide beta-strand mimics based on pyridinones, pyrazinones, pyridazinones, and triazinones
WO2005100334A1 (en) 2004-04-14 2005-10-27 Pfizer Products Inc. Dipeptidyl peptidase-iv inhibitors
US7405237B2 (en) 2004-07-28 2008-07-29 Celgene Corporation Isoindoline compounds and methods of their use
DE102005014245A1 (de) 2005-03-30 2006-10-05 Aicuris Gmbh & Co. Kg Antibakterielle Amid-Makrozyklen V
MY144590A (en) 2005-07-11 2011-10-14 Wyeth Corp Glutamate aggrecanase inhibitors
CN1943341B (zh) 2006-08-04 2012-05-09 华南农业大学 氨基酸与农药的藕合物及其制备方法与作为农药的应用
HUE035389T2 (en) 2006-09-26 2018-05-02 Celgene Corp 5-substituted quinazolinone derivatives as anticancer agents
WO2008156701A2 (en) 2007-06-13 2008-12-24 The Brigham And Women's Hospital, Inc. Hydroxamate inhibitors of insulin-degrading enzyme and uses thereof
WO2009078040A2 (en) 2007-12-17 2009-06-25 Debatosh Datta Compounds inducing reperfusion in ischaemic tissues
WO2009078039A2 (en) 2007-12-17 2009-06-25 Debatosh Datta Compound inducing angiogenesis response in ischaemic tissues
CZ305066B6 (cs) * 2008-02-25 2015-04-22 Zentiva, K.S. Způsob výroby (3R,4S)-1-(4-fluorfenyl)-3-[(3S)-3-(4-fluorfenyl)-3-hydroxypropyl)]-4-(4-hydroxyfenyl)-2-azetidinonu
WO2009131643A1 (en) 2008-04-21 2009-10-29 Monabio, Inc. Immunoassay for specific determination of s-adenosymethionine and analogs thereof in biological samples
CA2727925A1 (en) 2008-06-23 2009-12-30 Astrazeneca Ab New heterocyclic carboxamides for use as thrombin inhibitors
US8168756B2 (en) 2008-10-24 2012-05-01 Ark Diagnostics, Inc. Levetiracetam immunoassays
CA2746066A1 (en) 2008-12-09 2010-06-17 Sands Innovations Pty Ltd A dispensing container
SG183257A1 (en) 2010-02-11 2012-09-27 Celgene Corp Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
GB201007286D0 (en) * 2010-04-30 2010-06-16 Astex Therapeutics Ltd New compounds
CN102219834A (zh) 2011-04-14 2011-10-19 北京市丰硕维康技术开发有限责任公司 一种制备罗莫肽的方法
TWI547496B (zh) * 2011-10-04 2016-09-01 葛蘭素集團公司 抗菌化合物
HK1211577A1 (en) 2012-08-09 2016-05-27 细胞基因公司 Processes for the preparation of (s)-3-4- ((4-(morpholinomethyl) benzyl)oxy)-1-oxoisoindolin-2-yl) piperidine-2,6-dione and pharmaceutically acceptable forms thereof
US9695145B2 (en) 2013-01-22 2017-07-04 Celgene Corporation Processes for the preparation of isotopologues of 3-(4-((4- morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and pharmaceutically acceptable salts thereof
WO2016040527A1 (en) 2014-09-09 2016-03-17 Vanderbilt University Metabolism probes for therapy and diagnosis
NZ731789A (en) * 2014-10-30 2019-04-26 Kangpu Biopharmaceuticals Ltd Isoindoline derivative, intermediate, preparation method, pharmaceutical composition and use thereof
CN104826544B (zh) 2015-04-02 2016-09-28 中国石油大学(华东) 含有偶氮苯光敏基团的脂肽分子表面活性剂及其合成方法

Similar Documents

Publication Publication Date Title
ES2789798T3 (es) Procedimiento para la preparación de intermedios de N-[3-(aminometil)oxetan-3-il]carbamato
JP7100125B2 (ja) リボシクリブおよびその塩の改善された調製のためのプロセス
EP3237404B1 (en) Processes for preparing ask1 inhibitors
JP6985367B2 (ja) 新規化合物および方法
CA2919317A1 (en) Synthesis of biphenylalaninol via novel intermediates
EP3148968A1 (en) Processes for the preparation of -aminosulfone compounds
JP3224422B2 (ja) アミノ酸又はアミノ酸誘導体の還元アミン化法
AU693219B2 (en) Amino acid-derived diaminopropanols
HU229391B1 (hu) Intermedierek kinolonkarbonsav-származékok elõállítására
Effenberger et al. Amino acids; 13: Investigations on the synthesis of dl-serine from α-haloacrylic acid derivatives
CN115925615A (zh) 一种光学纯2-甲基哌啶-5-胺的制备方法
WO2009076502A1 (en) Methods for the preparation of hydroxy-substituted aryl sulfamide compounds
JPS5833877B2 (ja) ユウキカゴウブツニカンスルカイリヨウ
JP5004067B2 (ja) ベンジルオキシ含窒素環状化合物の製造法
EP4330229B1 (en) Method for producing pyrrolidine compound
KR20210154213A (ko) 치환된 2-[2-(페닐)에틸아미노]알칸아미드 유도체를 제조하는 방법
EP1572661B1 (en) Crystalline form of quinapril hydrochloride and process for preparing the same
KR20210010487A (ko) 리나글립틴 및 이의 염의 제조를 위한 중간체 및 방법
GB2317888A (en) Acridone derivatives and preparation of 8-hydroxy-imidazoacridinone derivatives
US7750153B2 (en) Process for the preparation of didanosine using novel intermediates
WO2025186427A1 (en) Process for the preparation of deucravacitinib and intermediates thereof and method for purifying deucravacitinib
WO2024185438A1 (ja) アジド化合物、アミン化合物、及びエドキサバンの製造方法
EP1236715B1 (en) Process for S-Aryl cysteine
KR20020032589A (ko) 할로겐화 일차 아민의 제조
JP2008505860A (ja) 2,3−ジアミノプロピオン酸誘導体のエナンチオマー体の製造方法。